Boron in drug design: Recent advances in the development of new therapeutic agents

GFS Fernandes, WA Denny, JL Dos Santos - European Journal of …, 2019 - Elsevier
Advances in the field of boron chemistry have expanded the application of this element in
Medicinal Chemistry. Boron-containing compounds represent a new class for medicinal …

[HTML][HTML] Aminoacyl-tRNA synthetases as therapeutic targets

NH Kwon, PL Fox, S Kim - Nature reviews Drug discovery, 2019 - nature.com
Aminoacyl-tRNA synthetases (ARSs) are essential enzymes for protein synthesis with
evolutionarily conserved enzymatic mechanisms. Despite their similarity across organisms …

[HTML][HTML] A systematic review of in vitro and in vivo activities of anti-Toxoplasma drugs and compounds (2006–2016)

M Montazeri, M Sharif, S Sarvi, S Mehrzadi… - Frontiers in …, 2017 - frontiersin.org
The currently available anti-Toxoplasma agents have serious limitations. This systematic
review was performed to evaluate drugs and new compounds used for the treatment of …

Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics

CS Francklyn, P Mullen - Journal of Biological Chemistry, 2019 - ASBMB
Aminoacyl-tRNA synthetases (ARSs) are universal enzymes that catalyze the attachment of
amino acids to the 3′ ends of their cognate tRNAs. The resulting aminoacylated tRNAs are …

Roles of aminoacyl-tRNA synthetases in immune regulation and immune diseases

A Nie, B Sun, Z Fu, D Yu - Cell death & disease, 2019 - nature.com
Aminoacyl-tRNA synthetases (ARSs) play a vital role in protein synthesis by linking amino
acids to their cognate transfer RNAs (tRNAs). This typical function has been well recognized …

A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue

E Sonoiki, CL Ng, MCS Lee, D Guo, YK Zhang… - Nature …, 2017 - nature.com
Benzoxaboroles are effective against bacterial, fungal and protozoan pathogens. We report
potent activity of the benzoxaborole AN3661 against Plasmodium falciparum laboratory …

A review on inactivation methods of Toxoplasma gondii in foods

A Mirza Alizadeh, S Jazaeri, B Shemshadi… - … and Global Health, 2018 - Taylor & Francis
Toxoplasmosis is an infection caused by Toxoplasma gondii, a widespread zoonotic
protozoan which poses a great threat to human health and economic well-being worldwide …

Exploration of aminoacyl-tRNA synthetases from eukaryotic parasites for drug development

J Gill, A Sharma - Journal of Biological Chemistry, 2023 - ASBMB
Parasitic diseases result in considerable human morbidity and mortality. The continuous
emergence and spread of new drug-resistant parasite strains is an obstacle to controlling …

Mode of action studies confirm on-target engagement of lysyl-tRNA synthetase inhibitor and lead to new selection marker for Cryptosporidium

JC Hanna, V Corpas-Lopez, S Seizova… - Frontiers in Cellular …, 2023 - frontiersin.org
Introduction Cryptosporidiosis is a leading cause of diarrheal-associated morbidity and
mortality, predominantly affecting children under 5 years old in low-and-middle-income …

Bicyclic azetidines kill the diarrheal pathogen Cryptosporidium in mice by inhibiting parasite phenylalanyl-tRNA synthetase

S Vinayak, RS Jumani, P Miller, MM Hasan… - Science Translational …, 2020 - science.org
Cryptosporidium is a protozoan parasite and a leading cause of diarrheal disease and
mortality in young children. Currently, there are no fully effective treatments available to cure …